Piper Jaffray Starts Fulgent Genetics (FLGT) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BTIG Starts Fulgent Genetics (FLGT) at Buy
October 24, 2016 7:32 AM EDTBTIG initiated coverage on Fulgent Genetics (NASDAQ: FLGT) with a Buy rating and a price target of $15.
Analyst Karen Koski said, "While the genetic testing market is not without challenges and competition is formidable, we believe Fulgents proprietary technology platform drives multiple sustainable... More
Credit Suisse Starts Fulgent Genetics (FLGT) at Outperform
October 24, 2016 6:30 AM EDTCredit Suisse initiates coverage on Fulgent Genetics (NASDAQ: FLGT) with a Outperform rating and a price target of $13.00.
Analyst Erin Wilson commented, "FLGT is a rapidly-growing genetic testing company, leveraging a proprietary technology platform to provide physicians with relevant diagnostic information. Its analytics platform... More



